ScreenerHero

MDXGMiMedx Group, Inc.

NAS · US · Healthcare · Biotechnology · mimedx.com
4.330USD-2.70%Mkt Cap: 631.14M $P/E: 108.25

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing i…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap631.14M $
Enterprise Value508.14M $
Revenue (TTM)355.17M $
Gross Profit345.62M $
Net Income (TTM)48.58M $
Revenue/Share2.398 USD
Last Price4.330 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees808
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)108.25
P/E (Forward)24.81
PEG2.88
EV/EBITDA24.89
EV/Revenue1.43
P/S1.76
P/B2.90
EPS (TTM)0.04
EPS (Forward)0.17
52W Range
3.03026% of range7.970
52W High7.970 USD
52W Low3.030 USD
Profitability
Gross Margin82.56%
Oper. Margin-28.69%
EBITDA Margin5.75%
Profit Margin11.60%
ROE18.94%
ROA14.18%
Growth
Revenue Growth-34.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF74.00M $
CapEx (TTM)1.03M $
FCF Margin11.66%
FCF Yield6.56%
Net Debt-118.63M $
Net Debt/EBITDA-5.81
Balance Sheet
Debt/Equity0.07
Current Ratio5.33
Quick Ratio4.60
Book Value/Sh1.482 USD
Cash/Share0.9320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3235:10000
Split DateApr 2, 2008
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+61.7%
Target Range6.000 USD – 8.000 USD
$6.000+61.7% to mean$8.000
# Analysts5
Ownership
Shares Out.145.76M
Float114.77M
Insiders2.14%
Institutions77.71%
Short Interest
Short Ratio6.2d
Short % Float7.32%
Short % Out.5.79%
Shares Short8.43M
Short (prev mo.)7.53M
Technical
SMA 504.089 (+5.9%)
SMA 2004.879 (-11.3%)
Beta1.41
S&P 52W Chg18.16%
Avg Vol (30d)1.34M
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)54.8
MACD0.0607
MACD Signal0.0650
MACD Hist.-0.0043
BB Upper4.418 USD
BB Middle4.255 USD
BB Lower4.093 USD
BB Width7.61%
ATR (14)0.1900 USD
Vol Ratio (20d)0.60x